cjc-1295/ ipamorelin Sleep & Sculpt Peptide Therapy in Chicago CJC1295 + Ipamorelin – Peptides

Cycle Length: 8 weeks is standard

Investigated for bone mineral density support in GH-deficient preclinical models

Most protocols stack them together because pressing both receptors at once creates a larger GH pulse than either one alone

When GHRP-6 activates this receptor, it can increase pulsatile GH release from the pituitary gland

This selectivity profile distinguishes the CJC-1295 No DAC + Ipamorelin combination from GHRH + non-selective GHRP combinations, potentially enabling chronic or repeated administration protocols without the complications of sustained HPA axis activationthough this remains speculative pending clinical validation

Our IGF-1 LR3 Peptide is stored and handled according to industry guidelines to ensure stability